Jianxin Chen, PH.D.

VICE PRESIDENT, COO

Position type

Dr. Jianxin Chen received his Ph.D. degree in organic chemistry from University of British Columbia, Canada, in 1991. He is a well established chemical professional and technical executive in the field of pharmaceutical and biotech industry with his near 30 years’ experience spanning from R&D in medicinal and process chemistry, product development, and RNA therapeutics to commercialization, business development, corporate leadership and administration. Before joining Ractigen Therapeutics, Dr. Chen worked as a scientist to executive in several biotech and pharmaceutical companies including Biomics Biotechnologies (VP/CTO), Acuitas Therapeutics (Director), Arbutus Pharmaceuticals, Neuftech Chemicals and Kinetek Pharmaceuticals. During his career as a consultant to and in collaboration with Alnylam Pharmaceuticals, he has played a pivotal role in developing technologies for systemic delivery of siRNA therapeutics, which led to the first ever commercial launch of FDA approved siRNA drug Onpattro.